Randomized Phase III Trial of Dose-dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin, or Gemcitabine and Cisplatin as Perioperative Chemotherapy for Patients with Muscle-invasive Bladder Cancer. Analysis of the GETUG/AFU V05 VESPER Trial Secondary Endpoints: Chemotherapy Toxicity and Pathological ResponsesChristian Pfister, Stéphane Culine, Laurent Guy et al.|European Urology|2020Cited by 246
Orally Administered Isoflavones Are Present as Glucuronides in the Human ProstateLaurent Guy, Claudine Manach, N. Védrine et al.|Nutrition and Cancer|2008Cited by 29